NYSE:AMN
AMN Healthcare Services, Inc. Stock News
$57.19
+0.0200 (+0.0350%)
At Close: Apr 24, 2024
Accuray's (ARAY) New Treatment Package to Boost Patient Outcome
01:53pm, Friday, 14'th Oct 2022 Zacks Investment Research
Accuray's (ARAY) latest automated breast cancer treatment package for the Radixact System is expected to extend and improve the quality of patients' lives.
AMN vs. DOCS: Which Stock Is the Better Value Option?
12:48pm, Friday, 14'th Oct 2022
AMN vs. DOCS: Which Stock Is the Better Value Option?
AMN Healthcare Services (AMN) Gains But Lags Market: What You Should Know
09:45pm, Thursday, 13'th Oct 2022 Zacks Investment Research
AMN Healthcare Services (AMN) closed the most recent trading day at $113.46, moving +1.53% from the previous trading session.
QuidelOrtho (QDEL) Reports Solid Preliminary Q3 Revenues
03:11pm, Thursday, 13'th Oct 2022 Zacks Investment Research
QuidelOrtho's (QDEL) revenue growth in the third quarter is likely to have been boosted by continued strength in its non-COVID-19 product sales.
3 Medical Stocks to Buy in 2022 for Long-Term Resilience
02:11pm, Thursday, 13'th Oct 2022 Zacks Investment Research
Here we discuss two Medical companies, VRTX, ISRG and AMN, that may prove to be wealth creators for investors over the long term on the back of their strong fundamentals.
AMN Healthcare Services (AMN) Dips More Than Broader Markets: What You Should Know
09:50pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
AMN Healthcare Services (AMN) closed at $111.75 in the latest trading session, marking a -1.51% move from the prior day.
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
04:19pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
Thermo Fisher (TMO) Launches New TaqPath Panel in Europe
03:19pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
This panel of Thermo Fisher (TMO), apart from detecting GI bacteria, also helps in identifying the root cause of an infection and administering the best suitable treatment fast.
Charles River's (CRL) New Launch to Boost Gene Therapy Workflow
02:22pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Charles River's (CRL) latest product offering is expected to streamline the pathway to GMP AAV vector manufacturing without significant process development.
If You Invested $1000 in AMN Healthcare Services a Decade Ago, This is How Much It'd Be Worth Now
12:30pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
AMN Healthcare to Hold Third Quarter 2022 Earnings Conference Call on Thursday, November 3, 2022
08:15pm, Monday, 10'th Oct 2022 GlobeNewswire Inc.
DALLAS, Oct. 10, 2022 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2022 financial results and fourth quarter 2022 outlo
AMN Healthcare to Hold Third Quarter 2022 Earnings Conference Call on Thursday, November 3, 2022
04:15pm, Monday, 10'th Oct 2022
DALLAS, Oct. 10, 2022 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2022 financial results and fourth quarter 2022 outlook
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
03:56pm, Monday, 10'th Oct 2022 Zacks Investment Research
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
AngioDynamics (ANGO) Q1 Earnings, Revenues Lag Estimates
03:19pm, Monday, 10'th Oct 2022 Zacks Investment Research
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2023.
Wall Street Analysts See a 28% Upside in AMN Healthcare (AMN): Can the Stock Really Move This High?
01:55pm, Monday, 10'th Oct 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.4% in AMN Healthcare (AMN). While the effectiveness of this highly sought-after metric is questionable, the
